The Latest Cardiac and Vascular News
Next-generation deliverability and control for peripheral embolization — available September 8, 2025 IRVINE, Calif., Sept. 8, 2025 /PRNewswire/ — ASAHI INTECC today announced the U.S. commercial launch of Veloute™ and Tellus™. These medical devices are indicated for angiography and…
MINNEAPOLIS, Sept. 4, 2025 /PRNewswire/ — VentureMed Group, Inc., a privately held leader in medical device innovations for arteriovenous (AV) access and peripheral arterial disease (PAD), was recently featured in a published study on the outcomes of FLEX VP + DCB in the Journal of…
CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Symphony® Thrombectomy System to treat pulmonary embolism (PE), a life-threatening condition caused by blood clots blocking an artery in the lungs. This clearance expands the use of Symphony – previously for the treatment of […]
MINNEAPOLIS, Aug. 29, 2025 /PRNewswire/ — Phraxis, Inc., a leader in vascular access innovation, today announced the successful completion of the first commercial case using the EndoForce™ Anastomotic Connector, marking a historic milestone in the treatment of dialysis patients worldwide….
Venova Medical Receives FDA IDE Approval for the VENOS-3 Study LOS GATOS, Calif., Aug. 21, 2025 /PRNewswire-PRWeb/ — Venova Medical, a privately held company developing a next generation technology for the creation of percutaneous arteriovenous fistulas (pAVF) for hemodialysis access, today announced approval from the US Food and Drug Administration (FDA) to […]
First and Only Liquid Embolic Approved for Hypervascular Tumor Embolization Supported by a Prospective, Randomized, Controlled, Clinical Trial BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ — Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular…
BEDFORD, Mass., Aug. 5, 2025 /PRNewswire/ — Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolization, has announced the appointment of Sean Boyle as Chief Executive Officer. I’m honored to join Instylla at such a crucial moment in…
PORTAGE, Mich., July 29, 2025 /PRNewswire/ — Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its next-generation InThrill Thrombectomy System, the first and only purpose-built small vessel and arteriovenous (AV) access…
Trial Investigates Use of Auryon Atherectomy System in Cases with Challenging Below-the-Knee Blockages LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced enrollment of the first […]
SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ — Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third iteration of the innovative device delivers…
